Beclomethasone dipropionate monohydrate nasal pharmaceutical formulations and methods of using the same

摘要: Nasal pharmaceutical formulations comprising a drug substance having specific particle size distribution profile are disclosed herein. Such provides increased bioavailability, efficacy or prolonged therapeutic effect of the when administered intranasally. The present invention may comprise one more corticosteroids profile. In preferred embodiment, corticosteroid is beclomethasone pharmaceutically acceptable derivative thereof for treatment symptoms rhinitis. Preferably, dipropionate. herein be provided as an aqueous suspension suitable inhalation via intranasal route.